Advertisement
Screener

Siga Technologies INC (SIGA) Additional Paid in Capital, Common Stock

1.6 / 5 stars · 32/98 Roast Me

Siga Technologies INC Additional Paid in Capital, Common Stock

Siga Technologies INC (SIGA) had Additional Paid in Capital, Common Stock of $243.26 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-06

  • 2026-06-30: Additional Paid in Capital, Common Stock $243.26M.
  • 2026-03-31: Additional Paid in Capital, Common Stock $242.06M.
  • 2025-12-31: Additional Paid in Capital, Common Stock $241.89M.
  • 2025-09-30: Additional Paid in Capital, Common Stock $241.11M.
Period endAdditional Paid in Capital, Common StockAdditional Paid in Capital, Common Stock as first filed
2026-06-30$243.26M
10-Q · filed 2026-08-06
2026-03-31$242.06M
10-Q · filed 2026-05-07
2025-12-31$241.89M
10-Q · filed 2026-08-06
2025-09-30$241.11M
10-Q · filed 2025-11-06
2025-06-30$240.58M
10-Q · filed 2025-08-05
2025-03-31$239.37M
10-Q · filed 2025-05-08
2024-12-31$238.64M
10-K · filed 2026-03-10
2024-09-30$238.03M
10-Q · filed 2024-11-07
2024-06-30$237.50M
10-Q · filed 2024-08-01
2024-03-31$236.77M
10-Q · filed 2024-05-07
2023-12-31$235.80M
10-K · filed 2025-03-11
2023-09-30$235.33M
10-Q · filed 2023-11-07
2023-06-30$234.87M
10-Q · filed 2023-08-08
2023-03-31$234.37M
10-Q · filed 2023-05-04
2022-12-31$233.96M
10-K · filed 2024-03-12
2022-09-30$233.27M
10-Q · filed 2022-11-03
2022-06-30$232.94M
10-Q · filed 2022-08-04
2022-03-31$226.43M
10-Q · filed 2022-05-05
2021-12-31$226.07M
10-K · filed 2023-03-02
2021-09-30$225.76M
10-Q · filed 2021-11-04
2021-06-30$225.68M
10-Q · filed 2021-08-05
2021-03-31$225.21M
10-Q · filed 2021-05-06
2020-12-31$224.98M
10-K · filed 2022-03-03
2020-09-30$221.59M
10-Q · filed 2020-11-05
2020-06-30$221.38M
10-Q · filed 2020-08-06
2020-03-31$221.06M
10-Q · filed 2020-05-06
2019-12-31$220.81M
10-K · filed 2021-03-04
2019-09-30$221.39M
10-Q · filed 2019-11-05
2019-06-30$220.77M
10-Q · filed 2019-08-06
2019-03-31$220.22M
10-Q · filed 2019-05-02
2018-12-31$218.70M
10-K · filed 2020-03-05
2018-09-30$220.65M
10-Q · filed 2018-11-06
2018-06-30$214.91M
10-Q · filed 2018-08-07
2018-03-31$214.56M
10-Q · filed 2018-05-04
2017-12-31$214.23M
10-K · filed 2019-03-06
2017-09-30$214.24M
10-Q · filed 2017-11-07
2017-06-30$213.84M
10-Q · filed 2017-08-03
2017-03-31$213.61M
10-Q · filed 2017-05-04
2016-12-31$213.71M
10-K · filed 2018-03-06
2016-09-30$177.53M
10-Q · filed 2016-11-02
2016-06-30$177.38M
10-Q · filed 2016-08-08
2016-03-31$177.20M
10-Q · filed 2016-05-04
2015-12-31$177.01M
10-K · filed 2017-03-07
2015-09-30$176.68M
10-Q · filed 2015-10-27
2015-06-30$176.32M
10-Q · filed 2015-08-04
2015-03-31$175.94M
10-Q · filed 2015-05-06
2014-12-31$175.48M
10-K · filed 2016-03-04
2014-09-30$174.95M
10-Q · filed 2014-11-04
2014-06-30$174.42M
10-Q · filed 2014-07-31
2014-03-31$173.84M
10-Q · filed 2014-05-01
2013-12-31$173.50M
10-K · filed 2015-03-06
2013-09-30$171.51M
10-Q · filed 2013-11-06
2013-06-30$170.69M
10-Q · filed 2013-08-05
2013-03-31$169.72M
10-Q · filed 2013-05-15
2012-12-31$167.59M
10-K · filed 2014-03-10
$152.34M
10-K · filed 2013-03-06
2012-09-30$151.94M
10-Q · filed 2012-11-05
2012-06-30$151.51M
10-Q · filed 2012-08-06
2012-03-31$150.87M
10-Q · filed 2012-05-07
2011-12-31$166.06M
10-K/A · filed 2013-05-15
$150.55M
10-K · filed 2012-03-01
2011-09-30$149.09M
10-Q · filed 2011-11-08
2011-06-30$146.27M
10-Q · filed 2011-08-01
2010-12-31$134.52M
10-K · filed 2012-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B